Dr. Butowski specializes in novel therapeutic approaches to brain tumors, clinical trials, neuro-imaging, cognitive and rehabilitative neurology, medical education, and complementary therapy. His ultimate research goal is to develop novel and effective therapeutic strategies for the treatment of patients with primary brain tumors. The most direct research application is the design and conduct of phase I, II, and III clinical trials, and Dr. Butowski is a co-investigator of National Cancer Institute-supported North American Brain Tumor Consortium clinical trials. As a member of the Brain Tumor Research Center at UCSF, his research goals have expanded to include the evaluation of novel imaging techniques and molecular profiling methods that may influence the selection of patients for treatment. His research interests also include methods and/or treatments to ensure good quality of life for patients with brain tumors and methods and/or treatments that may assist patients in recovering from or coping with brain injury. The majority of his clinical activities involve the assessment and management of adult patients with brain tumors.
April 1, 2014 - March 31, 2016 - A Phase I Study of CED of Liposomal-Irinotecan using imaging in High Grade Glioma, Principal Investigator. Sponsor: NIH/NCI, Sponsor Award ID: R21CA186140
April 1, 2014 - March 31, 2017 - A Phase I Study of CED of Liposomal-Irinotecan using imaging in High Grade Glioma, Principal Investigator. Sponsor: NIH, Sponsor Award ID: R21CA186140
Northwestern University, Evanston, IL, BA, 1991-1995, Philosophy/Religion
University of Illinois at Chicago, Chicago, IL, MD, 1995-1999
Evanston-Northwestern Hospital, Evanston, IL, Surgical Intern, 1999-2000
UCSF Department of Neurology, Resident, 2000-2003
UCSF Department of Neurological Surgery, Neuro-Oncology Fellow, 2003-2004